secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASPAC I Acquisition Corp. (—)
CIK:        0001868775
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001213900-24-020466
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ASCA shareholders approve NewGenIvf merger; seals up to $3.5M JAK convertible note facility
--------------------------------------------------------------------------------

- Shareholders voted 99.86% in favor (2,768,905 for vs 4,000 against) for all four business combination proposals at March 4 special meeting.
- Entered Securities Purchase Agreement with JAK Opportunities VI for two tranches totaling up to $3.5M principal amount of 12.75% convertible notes.
- Third Amendment to Merger Agreement issued 295,000 Commitment Shares to JAK for $1.75M initial tranche payable at business combination close.
- Agreed to pay Chardan $1M cash, 1.5M PubCo shares, and 30% of post-closing financing proceeds to satisfy deferred underwriting commission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868775/000121390024020466/0001213900-24-020466-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868775/000121390024020466/ea0201275-8k425_aspac1.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-020466

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer